- Home
- CELC vs BKV Comparison
CELC vs BKV Comparison
Compare CELC & BKV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | CELC | BKV |
|---|---|---|
| Founded | 2011 | 2015 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medical Specialities | Oil & Gas Production |
| Sector | Health Care | Energy |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 3.1B | 2.8B |
| IPO Year | 2017 | 2024 |
Fundamental Metrics
Financial Performance| Metric | CELC | BKV |
|---|---|---|
| Price | $104.77 | $26.60 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 8 | 6 |
| Target Price | ★ $100.13 | $31.17 |
| AVG Volume (30 Days) | 863.3K | ★ 869.4K |
| Earning Date | 11-12-2025 | 02-25-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ 0.53 |
| Revenue | N/A | ★ $822,525,000.00 |
| Revenue This Year | N/A | $56.14 |
| Revenue Next Year | N/A | $40.45 |
| P/E Ratio | ★ N/A | $50.84 |
| Revenue Growth | N/A | ★ 33.41 |
| 52 Week Low | $7.58 | $15.00 |
| 52 Week High | $112.64 | $29.65 |
Technical Indicators
Market Signals| Indicator | CELC | BKV |
|---|---|---|
| Relative Strength Index (RSI) | 63.88 | 47.18 |
| Support Level | $98.50 | $25.71 |
| Resistance Level | $103.09 | $28.32 |
| Average True Range (ATR) | 3.54 | 0.90 |
| MACD | -0.65 | -0.16 |
| Stochastic Oscillator | 78.85 | 35.69 |
Price Performance
Historical ComparisonAbout CELC Celcuity Inc.
Celcuity Inc is a clinical-stage biotechnology company pursuing development for oncology. The Company's lead therapeutic candidate is gedatolisib, a potent pan-PI3K and mTOR inhibitor. Its mechanism of action and pharmacokinetic properties are differentiated from other currently approved and investigational therapies that target PI3K or mTOR alone or together. A Phase 3 clinical trial, VIKTORIA-1, evaluating gedatolisib in combination with fulvestrant with or without palbociclib in patients with HR+/HER2- advanced breast cancer is currently enrolling patients.
About BKV BKV Corporation
BKV Corp is a growth-driven energy company. Its core business is production of natural gas from its owned and operated upstream businesses. It operates in four business lines: natural gas production, natural gas gathering, processing and transportation (natural gas midstream business), power generation and carbon capture, utilization, and sequestration (CCUS).